相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy
Seong-Ryul Kwon et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Structural Bone Changes in Spondyloarthritis: Mechanisms, Clinical Impact and Therapeutic Considerations
Georg Schett
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2011)
Osteoporosis: A Paradox in Ankylosing Spondylitis
Shea Carter et al.
Current Osteoporosis Reports (2011)
Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints
S. Uderhardt et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Evidence That Dkk-1 Is Dysfunctional in Ankylosing Spondylitis
Dimitrios Daoussis et al.
ARTHRITIS AND RHEUMATISM (2010)
Soluble receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation
Chun-Hsiung Chen et al.
CLINICAL RHEUMATOLOGY (2010)
Bone remodeling in rheumatic disease: a question of balance
Nicole C. Walsh et al.
IMMUNOLOGICAL REVIEWS (2010)
Osteoporosis in Ankylosing Spondylitis
Marina Magrey et al.
Current Rheumatology Reports (2010)
Osteoimmunology in rheumatic diseases
Georg Schett
ARTHRITIS RESEARCH & THERAPY (2009)
The role of Wnt proteins in arthritis
Georg Schett et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women
Nancy E. Lane et al.
ARTHRITIS AND RHEUMATISM (2007)
Dickkopf-1 is a master regulator of joint remodeling
Danielle Diarra et al.
NATURE MEDICINE (2007)
Elevated serum levels of soluble receptor activator of nuclear factors-κB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS)
H. -R. Kim et al.
RHEUMATOLOGY (2006)
Prostaglandin E2 strongly inhibits human osteoclast formation
I Take et al.
ENDOCRINOLOGY (2005)
分享论文
